Literature DB >> 19292644

20 years of HIV-2 infection in Portugal: trends and changes in epidemiology.

Emília Valadas, Luís França, Sara Sousa, Francisco Antunes.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19292644     DOI： 10.1086/597504

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  16 in total

1.  In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.

Authors:  Benoit Visseaux; Charlotte Charpentier; Margarita Hurtado-Nedelec; Alexandre Storto; Romain Antoine; Gilles Peytavin; Florence Damond; Sophie Matheron; Françoise Brun-Vézinet; Diane Descamps
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.

Authors:  F Damond; A Benard; Claudia Balotta; Jürg Böni; Matthew Cotten; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Jean Ruelle; Berta Rodes; Vicente Soriano; Mark Wainberg; Audrey Taieb; Sophie Matheron; Genevieve Chene; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Improving HIV-2 detection by a combination of serological and nucleic acid amplification test assays.

Authors:  Anna Rita Ciccaglione; Michela Miceli; Giulio Pisani; Roberto Bruni; Paola Iudicone; Angela Costantino; Michele Equestre; Elena Tritarelli; Cinzia Marcantonio; Paola Tataseo; Maria Cristina Marazzi; Susanna Ceffa; Giovanna Paturzo; Anna Maria Doro Altan; Massimo Magnano San Lio; Sandro Mancinelli; Massimo Ciccozzi; Alessandra Lo Presti; Giovanni Rezza; Leonardo Palombi
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

4.  A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Authors:  Shengwen Xiong; Pedro Borrego; Xiaohui Ding; Yuanmei Zhu; Andreia Martins; Huihui Chong; Nuno Taveira; Yuxian He
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Authors:  Julia Drylewicz; Serge Eholie; Moussa Maiga; Djimon Marcel Zannou; Papa Salif Sow; Didier K Ekouevi; Kevin Peterson; Emmanuel Bissagnene; François Dabis; Rodolphe Thiébaut
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

6.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

7.  HIV-2 infection in Providence, Rhode Island from 2002 to 2011.

Authors:  B L Hollenbeck; C G Beckwith
Journal:  HIV Med       Date:  2012-05-11       Impact factor: 3.180

8.  Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.

Authors:  Helena Barroso; Pedro Borrego; Inês Bártolo; José Maria Marcelino; Carlos Família; Alexandre Quintas; Nuno Taveira
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

9.  Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique.

Authors:  Cremildo Maueia; Deise Costa; Bindiya Meggi; Nalia Ismael; Carla Walle; Raphael Curvo; Celina Abreu; Nilesh Bhatt; Amilcar Tanuri; Ilesh V Jani; Orlando C Ferreira
Journal:  Virol J       Date:  2011-08-17       Impact factor: 4.099

10.  Prevalence of human immunodeficiency virus infection among transgender men in Rawalpindi (Pakistan).

Authors:  Hashaam Akhtar; Yasmeen Badshah; Samar Akhtar; Naghmana Kanwal; Maha Nadeem Akhtar; Najam Us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  Virol J       Date:  2012-10-08       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.